Summary:

• The global cardiac PoC testing devices market size reached USD 1.9 Billion in 2023.
• The market is expected to reach USD 3.0 Billion by 2032, exhibiting a growth rate (CAGR) of 5.33% during 2024-2032.
• North America leads the market, accounting for the largest cardiac PoC testing devices market share.
• Analyzers accounts for the majority of the market share in the product type segment due to their versatility and ease of use.
• Diagnostic laboratories represent the leading end user segment, owing to the continuous need for timely and reliable test results.
• The growing incidences of cardiovascular conditions is a primary driver of the cardiac PoC testing devices market.
• Technological advancements and the integration of biosensors, microfluidics, and mobile health applications are reshaping the cardiac PoC testing devices market.

Request to Get the Sample Report: https://www.imarcgroup.com/cardiac-poc-testing-devices-market/requestsample

Industry Trends and Drivers:

• Increasing Prevalence of Cardiovascular Diseases:

The rising prevalence of cardiovascular diseases (CVDs) across the globe is one of the major factors boosting the cardiac PoC testing devices market share. Moreover, the growing sedentary lifestyles, unhealthy diets, and increasing stress levels that contribute to the prevalence of heart-related ailments are creating a positive outlook for the market.

Besides this, the heightened focus of healthcare providers and policymakers on prioritizing early detection and intervention, leading to heightened demand for efficient diagnostic tools, is acting as a growth-inducing factor. Cardiac point-of-care (PoC) testing devices enable rapid assessment of cardiovascular health, allowing for immediate results and timely treatment. These devices are beneficial in emergency settings, where quick decision-making is crucial.

• Rapid Technological Advancements and Innovation:

The burgeoning integration of sophisticated technologies such as biosensors, microfluidics, and mobile health applications that enhance the accuracy and reliability of diagnostic tests is catalyzing the cardiac PoC testing devices market growth. These innovations facilitate faster and more precise results and enable healthcare providers to conduct tests in diverse settings, including home care and remote locations.

For instance, devices that utilize wireless technology can transmit patient data to healthcare professionals in real time, fostering improved patient management and follow-up care. Additionally, rapid advancements in artificial intelligence (AI) that pave the way for predictive analytics, which can identify at-risk individuals and facilitate proactive healthcare measures, are creating a positive outlook for the market.

• Ongoing Shift Towards Home Healthcare and Telemedicine:

The cardiac PoC testing devices market forecast highlights that the ongoing shift towards home healthcare and telemedicine is another significant factor propelling the market growth. Furthermore, the heightened need for remote monitoring and diagnostic solutions that minimize hospital visits and reduce healthcare costs is positively impacting the market growth.

Furthermore, the growing preference among patients for the convenience and comfort of testing at home, thus leading to a surge in demand for portable and user-friendly cardiac testing devices, is enhancing the market growth. Apart from this, the rapid advancements in digital health technologies that facilitate remote consultations and monitoring are fueling the cardiac PoC testing devices market size.

Speak to An Analyst: https://www.imarcgroup.com/request?type=report&id=7971&flag=C

Cardiac PoC Testing Devices Market Report Segmentation:

Breakup By Product Type:

• Cardiac Markers Test
  • Cardiac Troponin (cTn) Test
  • Myoglobin Test
  • Creatine Kinase MB Isoenzyme (CK-MB) Test
  • Combinational Test Kits
  • Brain Natriuretic Peptide (BNP) Test
• Analyzers

Analyzers account for the majority of shares due to their ability to provide accurate and rapid diagnostic results.

Breakup By End User:

• Hospitals
• Diagnostic Laboratories
• Others

Diagnostic laboratories exhibit a clear dominance as they require high volumes of testing for accurate disease diagnosis and management.

Breakup By Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

North America holds the leading position owing to a large market for cardiac PoC testing devices driven by its advanced healthcare infrastructure, high adoption rates of innovative medical technologies, increasing prevalence of cardiovascular diseases, and the emphasis on preventive healthcare.

Top Cardiac PoC Testing Devices Market Leaders: The cardiac PoC testing devices market research report outlines a detailed analysis of the competitive landscape, offering in-depth profiles of major companies.

Some of the key players in the market are:

• Abbott Laboratories
• ACON Laboratories Inc.
• Alfa Scientific Designs Inc.
• Bio-Rad Laboratories Inc.
• Danaher Corporation
• F. Hoffmann-La Roche AG
• LifeSign LLC
• Nano-Ditech Corporation
• Nexus-Dx Inc.

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world's most changemakers to create a lasting ambitious impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact US:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email:  sales@imarcgroup.com

Tel No:  (D) +91 120 433 0800

United States:  +1–631–791–1145

Content Source: https://blog.libero.it/wp/businessnews/2024/10/15/cardiac-poc-testing-devices-market-size-share-demand-key-players-forecast-analysis-2024-2032/